Monoceros Biosystems focuses on developing innovative biotechnological solutions aimed at advancing healthcare and improving patient outcomes. The company employs cutting-edge synthetic biology techniques to engineer microbial systems that can produce high-value biopharmaceuticals and therapeutic proteins. Their proprietary platform enables the design and optimization of these biological systems, facilitating the efficient production of complex molecules that are essential for modern medicine.

In addition to their synthetic biology capabilities, Monoceros Biosystems is also dedicated to harnessing the power of genomics and bioinformatics. By leveraging advanced data analysis and computational tools, the company aims to uncover insights into biological processes and enhance the development of their products. This integrated approach not only accelerates the discovery and development of new therapies but also positions Monoceros Biosystems at the forefront of biotechnological innovation, addressing critical needs in the healthcare sector.

United States

Applications of bioinformatics, genomics, and data mining technologies in drug discovery. Expertise in small molecule, antibody, and oligonucleotide target identification and validation. Discovery of novel pharmacodynamic, diagnostic, prognostic biomarkers and patient selection strategies.

Monoceros Biosystems

Company Details